A chimerism-based approach to induce tolerance in IgE-mediated allergy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Critical Reviews in Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1615/CRITREVIMMUNOL.V29.I5.20PMID 20001887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

  2009cited by this paper
• Allogeneic hematopoietic SCT for patients with autoimmune diseases

  2009cited by this paper
• Linking allergy to autoimmune disease.

  2009cited by this paper
• Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

  2009cited by this paper
• Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system.

  2009cited by this paper
• Hurdles to the Induction of Tolerogenic Mixed Chimerism

  2009cited by this paper
• B‐Cell Immunity in the Context of T‐Cell Tolerance after Combined Kidney and Bone Marrow Transplantation in Humans

  2009cited by this paper
• Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

  2009cited by this paper
• Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

  2009cited by this paper
• Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

  2009cited by this paper
• Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.

  2008cited by this paper
• Airway inflammation induced after allergic poly‐sensitization can be prevented by mucosal but not by systemic administration of poly‐peptides

  2008cited by this paper
• Long-Term Control of Alloreactive B Cell Responses by the Suppression of T Cell Help1

  2008cited by this paper
• Tolerization of a Type I Allergic Immune Response through Transplantation of Genetically Modified Hematopoietic Stem Cells1

  2008cited by this paper
• Clinical experience with mixed chimerism to induce transplantation tolerance

  2008cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2008cited by this paper
• T cell responses during allergen-specific immunotherapy of Type I allergy.

  2008cited by this paper
• Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

  2008cited by this paper
• Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

  2008cited by this paper
• Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

  2008cited by this paper
• Transplantation of Bone Marrow Transduced to Express Self-Antigen Establishes Deletional Tolerance and Permanently Remits Autoimmune Disease1

  2008cited by this paper
• Allergy and the cardiovascular system

  2008cited by this paper
• Will hematopoietic stem cell transplantation cure human autoimmune diseases?

  2008cited by this paper
• Gene therapy in type 1 diabetes.

  2008cited by this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• Recombinant allergens for immunotherapy.

  2007cited by this paper
• Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy1

  2007cited by this paper
• Tolerogenic property of MHC class I and class II molecules: lessons from a gene therapy approach.

  2007cited by this paper
• Homeostatic Expansion Permits T Cells to Re‐Enter the Thymus and Deliver Antigen in a Tolerogenic Fashion

  2007cited by this paper
• Induction of allograft tolerance in nonhuman primates and humans.

  2007cited by this paper
• Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data

  2007cited by this paper
• Hematopoietic-cell transplantation at 50.

  2007cited by this paper
• A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi‐sensitivities

  2007cited by this paper
• Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates

  2007cited by this paper
• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

  2007cited by this paper
• Costimulation Blockade Inhibits Allergic Sensitization but Does Not Affect Established Allergy in a Murine Model of Grass Pollen Allergy1

  2007cited by this paper
• Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

  2007cited by this paper
• Recent Progress in Tolerance Induction through Mixed Chimerism

  2007cited by this paper
• Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice

  2006cited by this paper
• The role of Foxp3+ T cells in long‐term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice

  2006cited by this paper
• Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.

  2006cited by this paper
• Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses

  2006cited by this paper
• Negative selection of the T‐cell repertoire: where and when does it occur?

  2006cited by this paper
• Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen.

  2006cited by this paper
• Induction of Alloreactive CD4 T Cell Tolerance in Molecular Chimeras: A Possible Role for Regulatory T Cells1

  2006cited by this paper
• Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

  2006cited by this paper
• Persistence of Antigen Is Required to Maintain Transplantation Tolerance Induced by Genetic Modification of Bone Marrow Stem Cells

  2006cited by this paper
• Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.

  2006cited by this paper
• Immunological mechanisms of allergen-specific immunotherapy

  2006cited by this paper
• CTLA4Ig: bridging the basic immunology with clinical application.

  2006cited by this paper
• Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus

  2006cited by this paper
• Origins of the T(H)1-T(H)2 model: a personal perspective.

  2006cited by this paper
• The Role of Non‐Deletional Tolerance Mechanisms in a Murine Model of Mixed Chimerism with Costimulation Blockade

  2005cited by this paper
• Epidemiology of life‐threatening and lethal anaphylaxis: a review

  2005cited by this paper
• High-Resolution Genome-Wide Mapping of Transposon Integration in Mammals

  2005cited by this paper
• Treatment of severe autoimmune disease by stem-cell transplantation

  2005cited by this paper
• Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival1

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.

  2005cited by this paper
• Allergen-specific immunotherapy with recombinant grass pollen allergens.

  2005cited by this paper
• Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

  2005cited by this paper
• Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice.

  2005cited by this paper
• Peptide-based therapeutic vaccines for allergic and autoimmune diseases

  2005cited by this paper
• Block and tackle: CTLA4Ig takes on lupus

  2005cited by this paper
• Molecular design of allergy vaccines.

  2005cited by this paper
• Oral tolerance

  2005cited by this paper
• Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

  2004cited by this paper
• Vaccine Engineering Improved by Hybrid Technology

  2004cited by this paper
• Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.

  2004cited by this paper
• Induction of Central Tolerance by Mature T Cells1

  2004cited by this paper
• Prevention of type 1 diabetes by gene therapy.

  2004cited by this paper
• A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.

  2004cited by this paper
• Vaccination with genetically engineered allergens prevents progression of allergic disease

  2004cited by this paper
• USE OF LENTIVIRAL VECTORS TO INDUCE LONG-TERM TOLERANCE TO GAL+ HEART GRAFTS

  2004cited by this paper
• Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.

  2003cited by this paper
• The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade.

  2003cited by this paper
• A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

  2003cited by this paper
• Tolerance established in autoimmune disease by mating or bone marrow transplantation that target autoantigen to thymus.

  2003cited by this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cited by this paper
• Stem cells engineered to express self-antigen to treat autoimmunity.

  2003cited by this paper
• Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral‐mediated gene transfer

  2003cited by this paper
• Gene Therapy Progress and Prospects: Gene therapy in organ transplantation

  2003cited by this paper
• Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy.

  2002cited by this paper
• Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System™

  2002cited by this paper
• Expression of Antigen on Mature Lymphocytes Is Required to Induce T Cell Tolerance by Gene Therapy1

  2002cited by this paper
• Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial.

  2002cited by this paper
• T cells mediate resistance to genetically modified bone marrow in lethally irradiated recipients1

  2002cited by this paper
• Induction of Central Deletional T Cell Tolerance by Gene Therapy1

  2002cited by this paper
• Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

  2002cited by this paper
• Engraftment of genetically modified bone marrow cells in sensitized hosts.

  2002cited by this paper
• The future of antigen-specific immunotherapy of allergy

  2002cited by this paper
• Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?

  2002cited by this paper
• From allergen structure to new forms of allergen-specific immunotherapy.

  2002cited by this paper
• Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.

  2001cited by this paper
• Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression1

  2001cited by this paper
• Transplantation tolerance from a historical perspective

  2001cited by this paper
• Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection

  2001cited by this paper
• Tolerance to solid organ transplants through transfer of MHC class II genes.

  2001cited by this paper

• Therapeutic induction of tolerance to reverse allergen-induced airway inflammation

  2015cites this paper
• Hematopoietic chimerisms: friends or foes?

  2014cites this paper
• The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism

  2013cites this paper
• Engraftment of retrovirally transduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance.

  2013cites this paper
• Persistent molecular microchimerism induces long‐term tolerance towards a clinically relevant respiratory allergen

  2012cites this paper
• Prevention of IgE-mediated allergy by molecular chimerism and costimulation blockade in a murine model

  2012cites this paper
• The antigenicity of the major grass pollen allergen Phl p 5 expressed in Balb/c mice

  2012cites this paper
• Expression of a Major Plant Allergen as Membrane-Anchored and Secreted Protein in Human Cells with Preserved T Cell and B Cell Epitopes

  2011cites this paper
• Cell-based therapy in allergy.

  2011cites this paper